Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, October 13, 2026

Back to today

From X

@aleabitoreddit

Serenity on X

"Potential FCC rules on optical transceivers more likely to come at 3.2T" - $LITE, $AAOI, $COHR, $SIVE. Morgan Stanley met with Washington officials: - Restrictions would likely start at 3.2T modules made in China (800g/1.6T would be left alone) - Potential restrictions would likely keep laser market tight (combining US DSPs + lasers could meet the 65% US value threshold per MS) - Chinese modules could qualify if 65% of bill of materials is US content. Chinese modules using US DSPs and lasers are already near that level - Analysts expect the positive impact on laser pricing... to be more important than any broad redistribution of transceiver market share. - Analysts don't expect this to bottleneck hyperscaler AI buildouts, they name InP substrate supply as the key variable to watch (hello $AXTI ) TLDR: Component suppliers in general are really positive. Like $SMTC probably winner here for TIAs/drivers (I don't think this was listed), maybe $MXL for DSPs too. $AAOI another large beneficiary. $SIVE is high-key alpha for laser beneficaries since they have "tremendous capacity" coming online, and that points to US foundries (they haven't formally disclosed location). Since previous slideshows show 2 US foundries 1 Taiwan foundry (Win Semi) in terms of their capacity partnerships. And it's process of elimination. From CIOE Channel checks it does look like they're starting to work with Chinese pluggable players, (so they'd avenues moving forward as US supply chain component beneficiaries). Of course $LITE / $COHR would be happy. TLDR: Western supply chains for Lasers / DSPs / TIAs / others are already bottlenecked but qualified capacity becomes even more important.
@KEDM_COM

KEDM.com on X

Qiagen $QGEN has a new CEO (Jonathan Pratt) per Sept. 1. Let's see if he can bring some action. The company also recently confirmed it continues to evaluate strategic alternatives, with Goldman Sachs involved. There have been reports of takeover interest for a long time, with past reports linking Qiagen to Thermo Fisher, bioMérieux, and Bio-Rad. Qiagen is an interesting target given its leadership in nucleic acid prep, strong consumables-driven revenue, and growth areas like TB testing and digital PCR. The portfolio would fit well with major industry consolidators.

Investor Letters

All letters

Vicor Update, Part Two

Vicor uses ITC exclusion-order cases to license power-module patents, with published royalty multipliers rising from 1.0x before filing to…

VICR $10B
CV's Substack 4 clicks

Expert Call | Nebius

Nebius’s 1 GW annual active-capacity target from 2027 is realistic, according to a former product manager, with greenfield data centers…

NBIS $56B
P Equity Research 4 clicks
PTRN · short

Pattern Group INC

Pattern Group is a fragile consumer business targeted on the short side.

PTRN $3B
Value Investors Club 3 clicks

“Is Ralph Lauren Still Relevant?”

Ralph Lauren’s 2017 CEO change put Patrice Louvet in charge of reversing nine quarters of same-store sales declines and restoring the…

RL $22B
TSOH Investment Research 1 click

Deep Dive: Inter & Co

Inter & Co, Brazil’s second-largest neobank, grew over 20% with controlled delinquencies and 15% book-value compounding while trading at…

INTR $3B
Capitalist Letters 7 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 49 of 229

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

88 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.